Form 8-K - Current report:
SEC Accession No. 0001193125-25-187680
Filing Date
2025-08-25
Accepted
2025-08-25 16:06:56
Documents
12
Period of Report
2025-08-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d88761d8k.htm   iXBRL 8-K 20953
  Complete submission text file 0001193125-25-187680.txt   133746

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA tngx-20250821.xsd EX-101.SCH 2849
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE tngx-20250821_lab.xml EX-101.LAB 17993
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tngx-20250821_pre.xml EX-101.PRE 11260
14 EXTRACTED XBRL INSTANCE DOCUMENT d88761d8k_htm.xml XML 3636
Mailing Address 201 BROOKLINE AVENUE SUITE 901 BOSTON MA 02215
Business Address 201 BROOKLINE AVENUE SUITE 901 BOSTON MA 02215 (857) 320-4900
Tango Therapeutics, Inc. (Filer) CIK: 0001819133 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)